DUSA Pharmaceuticals (DUSA) Tops Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts DUSA Hot Sheet
Price: $57.12 -0.07%
Financial Fact:
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING, DILUTED: 25.01M
Today's EPS Names:
CMCT, STEX, PWCM, More
Financial Fact:
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING, DILUTED: 25.01M
Today's EPS Names:
CMCT, STEX, PWCM, More
Join SI Premium – FREE
DUSA Pharmaceuticals (NASDAQ: DUSA) reported Q1 EPS of $0.08, $0.01 better than the analyst estimate of $0.07. Revenue for the quarter came in at $13.4 million versus the consensus estimate of $12.92 million.
For earnings history and earnings-related data on DUSA Pharmaceuticals (DUSA) click here.
For earnings history and earnings-related data on DUSA Pharmaceuticals (DUSA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
